糖心原创

School of Life Sciences
 

Kevin Fone

Emeritus Professor,

Contact

Biography

I graduated from Liverpool University in 1980 with a BSc in Pharmacology and continued in the same department to obtain a PhD on the central control of respiration in 1984. I then moved to the 糖心原创 and commenced an MRC post doctoral research fellowship with Professor CA Marsden and Dr GW Bennett, examining the role of serotonin (5-hydroxytryptamine, 5-HT) in bulbospinal raphe neurones controlling motor function. This established my long-standing interest in the mechanism of action of 5-HT in the CNS and Nottingham has since been my home for this research. In 1988 I was appointed to the position of Lecturer in the Department of Physiology and Pharmacology and I became a Senior lecturer in 1996, a Reader in 2003, and obtained a personal Chair in 2006 in what was then the School of Biomedical Sciences. I was elected a Fellow of the British Pharmacological Society in 2012 and became a Fellow of the British Association for Psychopharmacology (BAP) in 2024 when I was also awarded the BAP Outstanding Contribution Award. I became Emeritus Professor of Neuroscience in December 2021.

My work used a whole animal integrated physiological approach to investigate the functional role of 5-HT and dopamine in the CNS and to evaluate the impact of early-life interventions on brain development and behaviour. A particular interest was developing and validating rodent models that help improve our understanding of the neurobiological basis of common neurodevelopmental disorders. I have had extensive research collaborations with pharmaceutical companies around the world.

Teaching Summary

While I was a member of staff I delivered lectures to Neuroscience, MPharm and BMedSci degrees at The 糖心原创. During my time at The 糖心原创 I served as Admissions… read more

Research Summary

My research interest is the role of 5-hydroxytryptamine and dopamine in neurological and mental disorders and the impact of lesions, pharmacological or environmental interventions during early-life… read more

Selected Publications

  • DALL脡RAC G, LI X, LECOUFLET P, SACCHI S, ASSELOT R, PHAM TH, POTIER B, WATSON DJG, SCHMIDT S, LEVASSEUR G, FOSSAT P, BESEDIN A, RIVET JM, COYLE JT, COLLO G, POLLEGIONI L, KEHR J, GALANTE M, FONE KC, GARDIER AM, FRERET T, CONTARINO A, MILLAN MJ, and MOTHET JP, 2021. Proc Natl Acad Sci U S A. 118, e2023750118
  • BARNES NM, AHERN GP, BECAMEL C, BOCKAERT J, CAMILLERI M, CHAUMONT-DUBEL S, CLAEYSEN S, CUNNINGHAM KA and FONE KC, 2021. Pharmacological Reviews. 73, 310-520
  • FONE KCF, WATSON DJG, BILLIRAS RI, SICARD DI, DEKEYNE A, RIVET JM, GOBERT A and MILLAN MJ, 2021. Molecular Neurobiology. 57, 2144-2166
  • MILLAN MJ, DEKEYNE A, GOBERT A, BROCCO M, MANNOURY LA COUR C, ORTUNO JC, WATSON D and FONE KCF, 2021. Neuropharmacology. 177, 108099

While I was a member of staff I delivered lectures to Neuroscience, MPharm and BMedSci degrees at The 糖心原创. During my time at The 糖心原创 I served as Admissions tutor, Examination Officer and Senior Tutor for the undergraduate Neuroscience degrees and was a member of the Science Faculty Examination Board for the University. I supervised 46 successful PhD students and acted as External Examiner for over fifty PhD theses in UK, Germany, Italy, Sweden and Australia.

Current Research

My research interest is the role of 5-hydroxytryptamine and dopamine in neurological and mental disorders and the impact of lesions, pharmacological or environmental interventions during early-life on subsequent behavioural and neuronal development. My particular research focus is on the development and assessment of predictive models for schizophrenia, ADHD, depression and anxiety, and cognitive disorders. The fundamental approach is to concomitantly measure neurotransmitter function, neurochemistry and behaviour in paradigms designed to model CNS disorders. Techniques used include behavioural analysis, immunohistochemistry, radiotelemetry, microdialysis, electrophysiology, and MRI to identify changes in neuronal circuits in the brain that underlie the alterations in behaviour and neurophysiology seen. The aim is to gain a better understanding of the neurobiological aetiology of common CNS disorders, such as schizophrenia, depression and ADHD, and to help develop novel therapeutic treatment strategies.

  • BARNES NM, AHERN GP, BECAMEL C, BOCKAERT J, CAMILLERI M, CHAUMONT-DUBEL S, CLAEYSEN S, CUNNINGHAM KA and FONE KC, 2021. Pharmacological Reviews. 73, 310-520
  • DALL脡RAC G, LI X, LECOUFLET P, SACCHI S, ASSELOT R, PHAM TH, POTIER B, WATSON DJG, SCHMIDT S, LEVASSEUR G, FOSSAT P, BESEDIN A, RIVET JM, COYLE JT, COLLO G, POLLEGIONI L, KEHR J, GALANTE M, FONE KC, GARDIER AM, FRERET T, CONTARINO A, MILLAN MJ, and MOTHET JP, 2021. Proc Natl Acad Sci U S A. 118, e2023750118
  • LEAROYD AR, CALMUS R, CUNNINGHAM CN, ENGLAND TJ, FARR TD, FONE KCF and KENDALL DA, 2021. Wellcome Open Research. 6, 104
  • FONE KCF, WATSON DJG, BILLIRAS RI, SICARD DI, DEKEYNE A, RIVET JM, GOBERT A and MILLAN MJ, 2021. Molecular Neurobiology. 57, 2144-2166
  • MILLAN MJ, DEKEYNE A, GOBERT A, BROCCO M, MANNOURY LA COUR C, ORTUNO JC, WATSON D and FONE KCF, 2021. Neuropharmacology. 177, 108099
  • GOH J-Y, O'SULLIVAN SE, SHORTALL SE, ZORDAN N, PICCININI AM, POTTER HG, FONE KCF and KING MV, 2020. Brain, Behavior, and Immunity. 89, 100-117
  • KOHLI S, KING MV, WILLIAMS S, EDWARDS A, BALLARD TM, STEWARD LJ, ALBERATI D and FONE KCF, 2019. Neuropsychopharmacology. 44(2), 295-305
  • MORETON E, BARON P, TIPLADY S, MCCALL S, CLIFFORD B, LANGLEY-EVANS SC, FONE KCF and VOIGT JP, 2019. Behavioural Brain Research. 363, 191-198
  • MARSHALL HJ, PEZZE MA, FONE KCF and CASSADAY HJ, 2019. Neurobiology of Learning and Memory. 164, 107041
  • DUNPHY DOHERTY F, O鈥橫AHONY SM, PETERSON VL, O鈥橲ULLIVAN O, CRISPIE F, COTTER PD, WIGMORE P, KING MV, CRYAN JF and FONE KCF, 2018. Brain, Behavior and Immunity. 68, 261-273
  • MCGARRITY, STEPHANIE, MASON, ROB, FONE, KEVIN, PEZZE, MARIE and BAST, TOBIAS, 2017. Cerebral Cortex. 27(9), 4447鈥�4462
  • MCGARRITY S, MASON R, FONE KC, PEZZE M and BAST T, 2017. Cerebral cortex. 27, 4447鈥�4462
  • PEZZE MA, MARSHALL HJ, FONE KCF and CASSADAY HJ, 2017. Learning & Memory. 24, 310-317
  • LEAROYD AE, WOODHOUSE L, SHAW L, SPRIGG N, BERECZKI D, BERGE E, CASO V, CHRISTENSEN H, COLLINS R, CZLONKOWSKA A, EL ETRIBI A, FARR TD, GOMMANS J, LASKA AC, NTAIOS G, OZTURK S, POCOCK SJ, PRASAD K, WARDLAW JM, FONE KC, BATH PM, TRUEMAN RC and , 2017. Translational stroke research. 8(6), 541-548
  • RAFTER M, FONE KCF and MORAN PM, 2016. Glutamate pharmacological models relevant to schizophrenia and psychosis: Can a receptor occupancy normalisation approach reduce the gap between animal and human experiments?. In: Handbook of Behavioural Neuroscience, Modeling Psychopathological Dimensions of Psychiatry: Glutamate pharmacological models relevant to schizophrenia and psychosis: Can a receptor occupancy normalisation approach reduce the gap between animal and human experiments? Elsevier. (In Press.)
  • WATSON DJ, KING MV, GYERTY脕N I, KISS B, ADHAM N and FONE KC, 2016. European Neuropsychopharmacology. 26(2), 208-24
  • SHORTALL SE, SPICER CH, EBLING FJ, GREEN AR, FONE KC and KING MV, 2016. Addiction Biology. 21(6), 1127-1139
  • GASKIN PHILIP LR, TOLEDO-RODRIGUEZ MARIA, ALEXANDER STEVEN PH and FONE KEVIN CF, 2016. The International Journal of Neuropsychopharmacology. 19, pyw062 (In Press.)
  • SHORTALL, SINEAD E., GREEN, A. RICHARD, FONE, KEVIN C. F. and KING, MADELEINE V., 2016. JOURNAL OF PSYCHOPHARMACOLOGY. 30(7), 698-706
  • WATSON, DAVID J. G., KING, MADELEINE V., GYERTYAN, ISTVAN, KISS, BELA, ADHAM, NIKA and FONE, KEVIN C. F., 2016. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 26(2), 208-224
  • PEZZE MA, MARSHALL HJ, FONE KC and CASSADAY HJ, 2015. European Neuropsychopharmacology: Eur Neuropsychopharmacol. 25(11), 2145-56
  • SHORTALL SE, SPICER CH, EBLING FJ, GREEN AR, FONE KC and KING MV, 2015. Addiction Biology. 21(6), 1127-1139
  • NAPOLITANO, A., SHAH, K., SCHUBERT, M.I., PORKESS, V., FONE, K.C.F. and AUER, D.P., 2014. Schizophrenia Bulletin. 40(3), 566-574
  • ISLAHUDIN F, TINDALL SM, MELLOR IR, SWIFT K, CHRISTENSEN HEM, FONE KCF, PLEASS RJ, TING K and AVERY SV, 2014. Scientific Reports. 4, 3618
  • GREEN AR, KING MV, SHORTALL SE and FONE KCF, 2014. British Journal of Pharmacology. 171(9), 2251-2268
  • JONES S, FILECCIA EL, MURPHY M, FOWLER MJ, KING MV, SHORTALL SE, WIGMORE PM, GREEN AR, FONE KCF and EBLING FJP, 2014. Neuroscience letters. 559, 34-8
  • GASKIN PL, ALEXANDER SP and FONE KC, 2014. Psychopharmacology. 231(12), 2533-45
  • PEZZE M, MCGARRITY S, MASON R, FONE KC and BAST T, 2014. The Journal of neuroscience : the official journal of the Society for Neuroscience. 34(23), 7931-7946
  • MILLAN MJ, FONE K, STECKLER T and HORAN WP, 2014. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. 24(5), 645-92
  • NAPOLITANO, ANTONIO, SHAH, KHALID, SCHUBERT, MIRJAM I., PORKESS, VERONICA, FONE, KEVIN C. F. and AUER, DOROTHEE P., 2014. SCHIZOPHRENIA BULLETIN. 40(3), 566-574
  • KING, MADELEINE V., KURIAN, NISHA, QIN, SI, PAPADOPOULOU, NEKTARIA, WESTERINK, BEN H. C., CREMERS, THOMAS I., EPPING-JORDAN, MARK P., LE POUL, EMMANUEL, RAY, DAVID E., FONE, KEVIN C. F., KENDALL, DAVID A., MARSDEN, CHARLES A. and SHARP, TYSON V., 2014. NEUROPSYCHOPHARMACOLOGY. 39(2), 464-476
  • GASKIN, PHILIP L. R., ALEXANDER, STEPHEN P. H. and FONE, KEVIN C. F., 2014. PSYCHOPHARMACOLOGY. 231(12), 2533-2545
  • SHORTALL, S.E., GREEN, A.R., SWIFT, K.M., FONE, K.C.F. and KING, M.V., 2013. British Journal of Pharmacology. 168(4), 966-977
  • SHORTALL, S.E., MACEROLA, A.E., SWABY, R.T.R., JAYSON, R., KORSAH, C., PILLIDGE, K.E., WIGMORE, P.M., EBLING, F.J.P., GREEN, A.R., FONE, K.C.F. and KING, M.V., 2013. European Neuropsychopharmacology. 23(9), 1085-1095
  • MCINTOSH, A.L., BALLARD, T.M., STEWARD, L.J., MORAN, P.M. and FONE, K.C.F., 2013. Psychopharmacology. 228(1), 31-42
  • BODY S, CHEUNG THC, VALENCIA-TORRES L, OLARTE-S脕NCHEZ CM, FONE KCF, BRADSHAW CM and SZABADI E, 2013. Behavioural processes. 95, 71-89
  • BAY-RICHTER, C., O'CALLAGHAN, M.J., MATHUR, N., O'TUATHAIGH, C.M.P., HEERY, D.M., FONE, K.C.F, WADDINGTON, J.L. and MORAN, P.M., 2013. Neuropsychopharmacology. 38(8), 1512-1520
  • KING MV, KURIAN N, QIN S, PAPADOPOULOU N, WESTERINK BH, CREMERS TI, EPPING-JORDAN MP, LE POUL E, RAY DE, FONE KC, KENDALL DA, MARSDEN CA and SHARP TV, 2013. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. (In Press.)
  • WATSON, D.J.G., MARSDEN, C.A., MILLAN, M.J. and FONE, K.C.F., 2012. International Journal of Neuropsychopharmacology. 15(4), 471-484
  • WATSON, D.J.G., LOISEAU, F., INGALLINESI, M., MILLAN, M.J., MARSDEN, C.A. and FONE, K.C.F., 2012. Neuropsychopharmacology. 37(3), 770-786
  • DEKEYNE A, BROCCO M, LOISEAU F, GOBERT A, RIVET J, DI CARA B, CREMERS TI, FLIK G, FONE KCF, WATSON DJG, PAPP M, SHARP T, SERRES F, CESPUGLIO R, OLIVIER B, CHAN JSW, LAVIELLE G and MILLAN MJ, 2012. The Journal Of Pharmacology And Experimental Therapeutics. 340(3), 765-780
  • VALENCIA-TORRES L, OLARTE-S脕NCHEZ CM, BODY S, FONE KCF, BRADSHAW CM and SZABADI E, 2012. Behavioural Brain Research. 229(2), 372-7
  • WOODS S, CLARKE NN, LAYFIELD R and FONE KCF, 2012. British Journal of Pharmacology. 167, 436-449
  • GREEN AR, KING MV, SHORTALL SE and FONE KCF, 2012. British Journal of Pharmacology. 166(5), 1523-36
  • VALENCIA-TORRES L, OLARTE-S脕NCHEZ CM, BODY S, CHEUNG THC, FONE KCF, BRADSHAW CM and SZABADI E, 2012. Behavioural brain research. 235(2), 273-9
  • MEFFRE, J., CHAUMONT-DUBEL, S., MANNOURY LA COUR, C., LOISEAU, F., WATSON, D.J.G., DEKEYNE, A., S脡VENO, M., RIVET. J-M., GAVEN, F., D脡L脡RIS, P., HERV脡, D., FONE, K.C.F., BOCKAERT, J., MILLAN, M.J. and MARIN, P., 2012. EMBO Molecular Medicine. 4(10), 1043-1056
  • JONES, C A, WATSON, D J G and FONE, KCF, 2011. British Journal of Pharmacology. 164(4), 1162-94
  • JONES, CA, BROWN, AM, AUER, DP and FONE, KCF, 2011. Psychopharmacology. 214(1), 269-283
  • WRIGHT, T.M., FONE, K.C.F., LANGLEY-EVANS, S.C. and VOIGT, J.P.W., 2011. International Journal of Developmental Neuroscience. 29(8), 785-793
  • TORRES, LV, SANCHEZ, CMO, BODY, S, FONE, KCF, BRADSHAW, CM and SZABADI, E, 2011. Behavioral Neuroscience. 125(2), 202-214
  • RODSIRI, R, SPICER, C, GREEN, AR, MARSDEN, CA and FONE, KCF, 2011. Psychopharmacology. 213(2-3), 365-376
  • KENDALL, I, SLOTTEN, HA, CODONY, X, BURGUENO, J, PAUWELS, PJ, VELA, JM and FONE, KCF, 2011. Psychopharmacology. 213(2-3), 413-430
  • MARSDEN, C.A., KING, M.V. and FONE, K.C.F., 2011. Neuropharmacology. 61(3), 400-407
  • GREEN, AR, GABRIELSSON, J and FONE, KCF, 2011. British Journal of Pharmacology. 164(4), 1041-1043
  • MILLAN, MARK J, BUCCAFUSCO, JERRY J, LOISEAU, FLORENCE, WATSON, DAVID J G, DECAMP, EMMANUEL, FONE, KEVIN C F, THOMASSON-PERRET, NITZA, HILL, MICHAEL, MOCAER, ELISABETH and SCHNEIDER, JAY S, 2010. International Journal of Neuropsychopharmacology. 13(8), 1035-51
  • LE COZANNET, R., FONE, K.C.F. and MORAN, P.M., 2010. International Journal of Neuropsychopharmacology. 13(8), 1011-1020
  • RODSIRI, R, GREEN, AR, MARSDEN, CA and FONE, KCF, 2010. Journal Of Psychopharmacology. 24(2), 267-274
  • HAMPSON, CL, BODY, S, DEN BOON, FS, CHEUNG, THC, BEZZINA, G, LANGLEY, RW, FONE, KCF, BRADSHAW, CM and SZABADI, E, 2010. Behavioural Pharmacology. 21(1), 11-20
  • SCHUBERT, M I, PORKESS, M V, DASHDORJ, N, FONE, K C F and AUER, D P, 2009. Neuroscience. 159(1), 21-30
  • GREEN, A RICHARD, GABRIELSSON, JOHAN, MARSDEN, CHARLES A and FONE, KEVIN C F, 2009. Psychopharmacology. 204(2), 375-8
  • EASTON, N, MARSHALL, F H, MARSDEN, C A and FONE, K C F, 2009. Neuropharmacology. 57(7-8), 653-664
  • KING, M.V., SPICER, C.H., SLEIGHT, A.J., MARSDEN, C.A. and FONE, K.C.F., 2009. Psychopharmacology. 202(1-3), 111-123
  • BODY, S, CHEUNG, T H C, HAMPSON, C L, DEN BOON, F S, BEZZINA, G, FONE, K C F, BRADSHAW, C M and SZABADI, E, 2009. Psychopharmacology. 203(3), 547-59
  • KING, M.V., SEEMAN, P., MARSDEN, C.A. and FONE, K.C., 2009. Synapse. 63(6), 476-483
  • HEWITT, KN, MARSDEN, CA, HOLLIS, CP and FONE, KCF, 2009. Neuropharmacology. 57(7-8), 678-686
  • BIANCHI, M, FONE, KCF, SHAH, AJ, ATKINS, AR, DAWSON, LA, HEIDBREDER, CA, HAGAN, JJ and MARSDEN, CA, 2009. European Neuropsychopharmacology. 19(11), 778-790
  • BIANCHI, M, SHAH, AJ, FONE, KCF, ATKINS, AR, DAWSON, LA, HEIDBREDER, CA, HOWS, ME, HAGAN, JJ and MARSDEN, CA, 2009. Synapse. 63(4), 359-364
  • BEDFORD, L., HAY, D., DEVOY, A., PAINE, S., POWE, D.G., SETH, R., GRAY, T., TOPHAM, I., FONE, K., REZVANI, N., MEE, M., SOANE, T., LAYFIELD, R., SHEPPARD, P.W., EBENDAL, T., USOSKIN, D., LOWE, J. and MAYER, R.J., 2008. Journal of Neuroscience. 28(33), 8189-8198
  • GREEN, A R, MARSDEN, C A and FONE, K C F, 2008. Journal of Psychopharmacology. 22, 929-931
  • FONE, K C F and PORKESS, M V, 2008. Neuroscience & Biobehavioral Reviews. 32, 1087-1102
  • KING, MADELEINE V, MARSDEN, CHARLES A and FONE, KEVIN C F, 2008. Trends in Pharmacological Sciences. 29(9), 482-92
  • FONE, K.C.F., 2008. Neuropharmacology. 55, 1015-1022
  • EASTON,N., MARSHALL,F., FONE,K. and MARSDEN,C, 2007. Neuropharmacology. 52(3), 812-826
  • EASTON, N, STEWARD, C, MARSHALL, F, FONE, K C F and MARSDEN, C A, 2007. Neuropharmacology. 52(2), 405-414
  • CHEUNG, T H C, BEZZINA, G, BODY, S, FONE, K C F, BRADSHAW, C M and SZABADI, E., 2007. Psychopharmacology. 192, 521-535
  • EASTON, NEIL, MARSHALL, FIONA, FONE, KEVIN C F and MARSDEN, CHARLES A, 2007. Psychopharmacology. 193(1), 11-30
  • FINN, DAVID P, FONE, KEVIN C F, BECKETT, SIMON R G, BAXTER, JONATHAN A, ANSELL, LUCY, MARSDEN, CHARLES A and CHAPMAN, VICTORIA, 2007. European Journal of Pharmacology. 569(1-2), 59-63
  • NUTT, D J, FONE, K, ASHERSON, P, BRAMBLE, D, HILL, P, MATTHEWS, K, MORRIS, K A, SANTOSH, P, SONUGA-BARKE, E, TAYLOR, E, WEISS, M, YOUNG, S and ,, 2007. Journal of Psychopharmacology. 21(1), 10-41
  • CHEUNG,T.H.C., BEZZINA,G., HAMPSON,C.L., BODY,S., FONE,K.C.F., BRADSHAW,C.M. and SZABADI,E., 2007. Psychopharmacology. 195(2), 213-222
  • CHEUNG, T H C, BEZZINA, G, HAMPSON, C L, BODY, S, FONE, K C F, BRADSHAW, C M and SZABADI, E, 2007. Psychopharmacology. 193(3), 423-36
  • EASTON, N., SHAH, Y.B., MARSHALL, F.H., FONE, K.C. and MARSDEN, C.A, 2006. Psychopharmacology. 189(3), 369-385
  • CHEUNG, T.H.C, BEZZINA, G., ASGARI, K., BODY, S., FONE, K.C.F., BRADSHAW, C.M. and SZABADI, E., 2006. Psychopharmacology. 185(3), 378-388
  • BIANCHI, M, FONE, K F C, AZMI, N, HEIDBREDER, C A, HAGAN, J J and MARSDEN, C A, 2006. European Journal of Neuroscience. 24(10), 2894-2902
  • BODY, S, CHEUNG, T H C, BEZZINA, G, ASGARI, K, FONE, K C F, GLENNON, J C, BRADSHAW, C M and SZABADI, E, 2006. Psychopharmacology. 189(3), 331-43
  • BODY, S, ASGARI, K, CHEUNG, T.H.C., BEZZINA, G, FONE, K.F.C., GLENNON, J.C, BRADSHAW, C.M. and SZABADI, E., 2006. Behavioural Processes. 71(2-3), 258-67
  • BULL, E J, PORKESS, V, RIGBY, M, HUTSON, P H and FONE, K C F, 2006. Journal of Psychopharmacology. 20(2), 272-80
  • SLOTTEN, HELGE A, KALINICHEV, MIKHAIL, HAGAN, JIM J, MARSDEN, CHARLES A and FONE, KEVIN C F, 2006. Brain Research. 1097(1), 123-32
  • ASGARI, KARIM, BODY, STEPHANIE, BAK, VICTORIA K, ZHANG, ZHONG-QI, RICKARD, JONATHAN F, GLENNON, JEFFREY C, FONE, KEVIN C F, BRADSHAW, CHRISTOPHER M and SZABADI, ELEMER, 2006. Behavioural Pharmacology. 17(1), 51-9
  • ASGARI, K, BODY, S, ZHANG, Z, FONE, K C F, BRADSHAW, C M and SZABADI, E, 2006. Behavioural Processes. 71(2-3), 250-7
  • SCHUHLER, S., CLARK, A., JOSEPH, W., PATEL, A., LEHNEN, K., STRATFORD, E., HORAN, T. L., FONE, K. C. F. and EBLING, F. J. P, 2005. Journal of Neuroendocrinology. 17(5), 276-285
  • BODY, S., ASGARI, K., RICKARD, J. F., ZHANG, Z., FONE, K. C., BRADSHAW, C. M. and SZABADI, E., 2005. Psychopharmacology. VOL 181(NUMBER 2), 289-298
  • HEWITT, K.N., SHAH, Y.B., PRIOR, M.J.W., MORRIS, P.G., HOLLIS, C.P., FONE, K.C.F. and MARSDEN, C.A., 2005. Psychopharmacology. 180(4), 716-723
  • GUSCOTT, M, BRISTOW, L J, HADINGHAM, K, ROSAHL, T W, BEER, M S, STANTON, J A, BROMIDGE, F, OWENS, A P, HUSCROFT, I, MYERS, J, RUPNIAK, N M, PATEL, S, WHITING, P J, HUTSON, P H, FONE, K C, BIELLO, S M, KULAGOWSKI, J J and MCALLISTER, G, 2005. Neuropharmacology. 48(4), 492-502
  • FONE, KEVIN C F and NUTT, DAVID J, 2005. Current Opinion in Pharmacology. 5(1), 87-93
  • BULL, E.J., HUTSON, P.H. and FONE, K.C.F, 2004. Neuropharmacology. 46(2), 202-210
  • WOOLLEY, MARIE L, MARSDEN, CHARLES A and FONE, KEVIN C F, 2004. Current Drug Targets - CNS and Neurological Disorders. 3(1), 59-79
  • FINN, D P, BECKETT, S R G, ROE, C H, MADJD, A, FONE, K C F, KENDALL, D A, MARSDEN, C A and CHAPMAN, V, 2004. European Journal of Neuroscience. 19(3), 678-86
  • KING, MV, SLEIGHT, AJ, WOOLLEY, ML, TOPHAM, IA, MARSDEN, CA and FONE, KCF, 2004. Neuropharmacology. 47(2), 195-204
  • BULL, E J, HUTSON, P H and FONE, K C F, 2003. Neuropharmacology. 44(4), 439-48
  • BUSH, V L, MIDDLEMISS, D N, MARSDEN, C A and FONE, K C F, 2003. Journal of Neuroendocrinology. 15(6), 607-13
  • WOOLLEY, MARIE L, MARSDEN, CHARLES A, SLEIGHT, ANDREW J and FONE, KEVIN C F, 2003. Psychopharmacology. 170(4), 358-67
  • GUSCOTT, M. R., EGAN, E., COOK, G. P., STANTON, J. A., BEER, M. S., ROSAHL, T. W., HARTMANN, S., KULAGOWSKI, J., MCALLISTER, G. and FONE, K. C., 2003. Neuropharmacology. VOL 44(NUMBER 8), 1031-1037
  • FONE, K. C., BECKETT, S. R., TOPHAM, I. A., SWETTENHAM, J., BALL, M. and MADDOCKS, L., 2002. Psychopharmacology. 159(4), 437-444
  • KOGAN, HELEN A, MARSDEN, CHARLES A and FONE, KEVIN C F, 2002. European Journal of Pharmacology. 449(1-2), 105-11
  • FONE, KEVIN C F and TOPHAM, IAN A, 2002. Pharmacology, Biochemistry and Behavior. 71(4), 815-23
  • WOOLLEY, M.L., BENTLEY, J.C., SLEIGHT, A.J., MARSDEN, C.A. and FONE, K.C, 2001. Neuropharmacology. 41(2), 210-9
  • SPROSON, E. J., CHANTREY, J., HOLLIS, C., MARSDEN, C. A. and FONE, K. C. F., 2001. Journal of Psychopharmacology. VOL 15(PART 2), 67-75
  • MILLAN MJ, DEKEYNE A, GOBERT A, BROCCO M, MANNOURY LA COUR C, ORTUNO JC, WATSON D and FONE KCF, Neuropharmacology. 177, 108099

School of Life Sciences

糖心原创
Medical School
Queen's Medical Centre
Nottingham NG7 2UH

e: life-sciences@nottingham.ac.uk
t: +44 (0)115 823 0141
f: +44 (0)115 823 0142